October Pharma Co. (OCPH) Financials
Annual financial statement highlights for October Pharma Co. covering fiscal years 2014–2020. Figures are updated weekly.
| Fiscal year | Revenue | Net income | EPS | Free cash flow | Total assets | Total debt | Dividend per share |
|---|---|---|---|---|---|---|---|
| 2020ended Dec 2020 | 544.13M | 88.26M | 3.68 | 15.74M | 606.15M | 234.15M | 0.75 |
| 2019ended Dec 2019 | 523.72M | 33.83M | 1.41 | 62.83M | 545.89M | 257.44M | 0.38 |
| 2018ended Dec 2018 | 400.84M | 18.32M | 0.76 | -83.45M | 551.15M | 309.97M | 0.25 |
| 2017ended Dec 2017 | 350.16M | 50.48M | 1.97 | -41.85M | 366.75M | 100.06M | 1.00 |
| 2016ended Dec 2016 · 24 months | 288.11M | 35.13M | 1.46 | 76.78M | 254.2M | 17.59M | 0.88 |
| 2014ended Dec 2014 | 202.07M | 7.84M | 0.33 | 1.97M | 226.16M | 49.96M | 0.13 |
All figures in EGP, as reported in the company’s annual results; updated weekly.